EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hepatitis C and heart transplantation: An update

Marina Nunez iD, Anita A Kelkar

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Marina Nunez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section on Infectious Diseases, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, North Carol…. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C, Heart Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are limited data regarding heart transplantation in the setting of hepatitis C virus (HCV) infection in either recipients or donors, as the practice was infrequent, given concerns of worse post‐transplant outcomes. This changed dramatically after the development of highly effective HCV therapies, namely direct‐acting antivirals (DAAs). Additionally, nucleic acid testing currently in use establishes more precisely the risk of HCV transmission from donors. As a result, chronic HCV infection in itself is no longer a barrier for heart transplant candidates, and the use of HCV‐positive organs for HCV‐infected and non‐infected transplant candidates has increased dramatically. A review of the literature revealed that in the pre‐DAA era, HCV seropositive heart transplant patients had a higher mortality than their seronegative counterparts. However, short‐term data suggest that the differences in survival have been erased in the DAA era. Heart transplantation from HCV‐viremic donors to HCV‐uninfected recipients has become increasingly common as the number of deceased donors with HCV viremia has increased over the past years. Preliminary outcome reports are very encouraging, although further data are needed with regard to long‐term safety. New information continues to be incorporated to optimize protocols that guide this practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicHepatitis CHeart TransplantationHumansHepacivirusAntiviral AgentsTissue Donors

Stichwörter der Autor:innen

DAAsHCVHCV mismatch transplantheart transplantationoutcomes

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Section on Infectious Diseases, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, North Carolina, USA.
  • U.S. Department of Veterans Affairs, Kernersville VA Health Care System, Kernesville, North Carolina, USA.

ORCID-Profile: Marina Nunez

Zitieren

APA

Nunez, M., & Kelkar, A. A. (2023). Hepatitis C and heart transplantation: An update. Clinical Transplantation. https://doi.org/10.1111/ctr.15111

Vancouver

Nunez M, Kelkar AA. Hepatitis C and heart transplantation: An update. Clinical Transplantation. 2023. doi:10.1111/ctr.15111

BibTeX
@article{Nunez2023,
  author = {Nunez, Marina and Kelkar, Anita A},
  title = {Hepatitis C and heart transplantation: An update},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15111}
}
Kostenlos starten →